SAN DIEGO, June 3, 2015 /PRNewswire/ -- aTyr Pharma, Inc. (NASDAQ: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, today announced the Company’s participation at the 35th Annual William Blair Growth Stock Conference to be held at the Four Seasons Hotel in Chicago, IL, June 9-11, 2015.
John Mendlein, aTyr’s CEO and Executive Chairman, is scheduled to make a presentation on the Company at 9:20 a.m. CT on Wednesday, June 10, 2015. The presentation will be webcast live through the “Investors” section of the aTyr Pharma website at www.atyrpharma.com. An archived audio replay will be available for 30 days following the initial presentation webcast.
About aTyr Pharma
aTyr Pharma is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of Physiocrine biology, a newly discovered set of physiological modulators. The Company’s lead candidate, Resolaris, is a first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an immune component.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/atyr-pharma-to-present-at-35th-annual-william-blair-growth-stock-conference-300093048.html
SOURCE aTyr Pharma, Inc.
Help employers find you! Check out all the jobs and post your resume.
